Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fibronectin coating of collagen modules increases in vivo HUVEC survival and vessel formation in SCID mice.

Acta biomaterialia·2010
Same author

Complement inhibition reduces material-induced leukocyte activation with PEG modified polystyrene beads (Tentagel) but not polystyrene beads.

Journal of biomedical materials research. Part A·2005
Same author

Viability of hydroxyethyl methacrylate-methyl methacrylate-microencapsulated PC12 cells after omental pouch implantation within agarose gels.

Tissue engineering·2003
Same author

Material-induced tissue factor expression but not CD11b upregulation depends on the presence of platelets.

Journal of biomedical materials research. Part A·2003
Same author

Tissue engineering as a platform for controlled release of therapeutic agents: implantation of microencapsulated dopamine producing cells in the brains of rats.

Journal of controlled release : official journal of the Controlled Release Society·2001
Same author

Leukocyte activation and leukocyte procoagulant activities after blood contact with polystyrene and polyethylene glycol-immobilized polystyrene beads.

The Journal of laboratory and clinical medicine·2001
Same journal

Erratum to: Immunotherapeutic Approach to Cancer with Cutaneous DNA Vaccination.

Methods in molecular medicine·2015
Same journal

Methods for cancer gene therapy using tumor suppressor genes.

Methods in molecular medicine·2014
Same journal

Suppression of the human carcinoma phenotype by an antioncogene ribozyme.

Methods in molecular medicine·2014
Same journal

Methods for the use of stromal cells for therapeutic gene therapy.

Methods in molecular medicine·2014
Same journal

Methods for adenovirus-mediated gene transfer to synovium in vivo.

Methods in molecular medicine·2014
Same journal

Methods for gene transfer to synovium.

Methods in molecular medicine·2014
See all related articles

Related Experiment Video

Updated: Jun 4, 2026

Gelatin Methacryloyl Granular Hydrogel Scaffolds: High-throughput Microgel Fabrication, Lyophilization, Chemical Assembly, and 3D Bioprinting
10:36

Gelatin Methacryloyl Granular Hydrogel Scaffolds: High-throughput Microgel Fabrication, Lyophilization, Chemical Assembly, and 3D Bioprinting

Published on: December 9, 2022

Methods for Microencapsulation with HEMA-MMA.

S Lahooti1, M V Sefton

  • 1Department of Chemical Engineering and Applied Chemistry, University of Toronto, Ontario, Canada.

Methods in Molecular Medicine
|March 4, 2011
PubMed
Summary
This summary is machine-generated.

Cell encapsulation in a permselective membrane can prevent immune rejection of transplanted cells. This immunoisolation technique may reduce the need for immunosuppressive drugs and enable xenogeneic cell therapies.

More Related Videos

Cellular Encapsulation in 3D Hydrogels for Tissue Engineering
09:37

Cellular Encapsulation in 3D Hydrogels for Tissue Engineering

Published on: October 26, 2009

Mammalian Cell Encapsulation in Alginate Beads Using a Simple Stirred Vessel
10:20

Mammalian Cell Encapsulation in Alginate Beads Using a Simple Stirred Vessel

Published on: June 29, 2017

Related Experiment Videos

Last Updated: Jun 4, 2026

Gelatin Methacryloyl Granular Hydrogel Scaffolds: High-throughput Microgel Fabrication, Lyophilization, Chemical Assembly, and 3D Bioprinting
10:36

Gelatin Methacryloyl Granular Hydrogel Scaffolds: High-throughput Microgel Fabrication, Lyophilization, Chemical Assembly, and 3D Bioprinting

Published on: December 9, 2022

Cellular Encapsulation in 3D Hydrogels for Tissue Engineering
09:37

Cellular Encapsulation in 3D Hydrogels for Tissue Engineering

Published on: October 26, 2009

Mammalian Cell Encapsulation in Alginate Beads Using a Simple Stirred Vessel
10:20

Mammalian Cell Encapsulation in Alginate Beads Using a Simple Stirred Vessel

Published on: June 29, 2017

Area of Science:

  • Biomedical Engineering
  • Immunology
  • Regenerative Medicine

Background:

  • Cell encapsulation is a promising strategy to mitigate immune responses against transplanted cells.
  • Physical isolation via encapsulation can prevent immune rejection, reducing reliance on immunosuppressive therapies.
  • This approach could enable the use of xenogeneic cells for therapeutic purposes.

Purpose of the Study:

  • To explore the potential of cell encapsulation for immune control in transplantation.
  • To highlight the role of permselective membranes in facilitating nutrient exchange while blocking immune mediators.
  • To discuss various immunoisolation device designs, including microcapsules.

Main Methods:

  • Review of existing literature on cell encapsulation and immunoisolation devices.
  • Analysis of the principles of permselectivity in capsule membranes.
  • Discussion of different device geometries such as shunts, diffusion chambers, and microcapsules.

Main Results:

  • Encapsulation effectively isolates cells, preventing immune system attack.
  • Permselective membranes allow essential molecule transport (nutrients, growth factors, therapeutic products) while excluding immune components.
  • Various immunoisolation device types have been developed, including microcapsules.

Conclusions:

  • Cell encapsulation is a viable strategy for controlling immune responses in cell transplantation.
  • The design of permselective membranes is crucial for successful cell encapsulation.
  • Immunoisolation technologies, particularly microcapsules, offer a pathway for advanced cell-based therapies.